{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:53:41Z","timestamp":1764093221006,"version":"3.45.0"},"reference-count":133,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443294143"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apcsb.2025.08.009","type":"book-chapter","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T11:10:36Z","timestamp":1756552236000},"page":"481-505","source":"Crossref","is-referenced-by-count":0,"title":["The calpain-mediated proteolytic cleavage peptide P10 modulates Tau phosphorylation in Alzheimer\u2019s disease"],"prefix":"10.1016","member":"78","reference":[{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"2015 Alzheimer\u2019s disease facts and figures","volume":"11","author":"Alzheimer\u2019s","year":"2015","journal-title":"Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.08.009_bib2","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1039\/b409157d","article-title":"Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes","volume":"2","author":"Andrews","year":"2004","journal-title":"Organic & Biomolecular Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiological Reviews"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.009_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2174\/138955712800626728","article-title":"Meridianins: Marine-derived potent kinase inhibitors","volume":"12","author":"Bharate","year":"2012","journal-title":"Mini Reviews in Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: An update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochemical Journal"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.009_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nature Reviews Neuroscience"},{"issue":"48","key":"10.1016\/bs.apcsb.2025.08.009_bib8","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1021\/acs.biochem.0c00585","article-title":"HDAC6 ZnF UBP as the modifier of tau structure and function","volume":"59","author":"Balmik","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3233\/JAD-170900","article-title":"Multi-faceted role of melatonin in neuroprotection and amelioration of tau aggregates in Alzheimer\u2019s disease","volume":"62","author":"Balmik","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151202","article-title":"Inter-relationship of histone deacetylase-6 with tau-cytoskeletal organization and remodeling","volume":"101","author":"Balmik","year":"2022","journal-title":"European Journal of Cell Biology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2019.129467","article-title":"Melatonin interacts with repeat domain of tau to mediate disaggregation of paired helical filaments","volume":"1864","author":"Balmik","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib12","series-title":"Alzheimer\u2019s disease: Recent findings in pathophysiology, diagnostic and therapeutic modalities (pp. 0)","article-title":"Aggregation species of amyloid-\u03b2 and tau oligomers in Alzheimer\u2019s disease: Role in therapeutics and diagnostics","author":"Balmik","year":"2022"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12964-021-00736-9","article-title":"The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of tau","volume":"19","author":"Balmik","year":"2021","journal-title":"Cell Communication and Signaling"},{"issue":"13","key":"10.1016\/bs.apcsb.2025.08.009_bib14","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.1074\/jbc.M107565200","article-title":"Identification of the critical features of a small peptide inhibitor of JNK activity","volume":"277","author":"Barr","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"48","key":"10.1016\/bs.apcsb.2025.08.009_bib15","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1002\/anie.201105493","article-title":"The dynamic structure of filamentous tau","volume":"50","author":"Bibow","year":"2011","journal-title":"Angewandte Chemie International Edition"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-160458","article-title":"Profiling of p5, a 24 amino acid inhibitory peptide derived from the CDK5 activator, p35 CDKR1 against 70 protein kinases","volume":"54","author":"Binukumar","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.009_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1358\/dnp.2006.19.8.1043961","article-title":"The role of CDK5\/P25 formation\/inhibition in neurodegeneration","volume":"19","author":"Camins","year":"2006","journal-title":"Drug News & Perspectives"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0896-6273(01)80044-1","article-title":"Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality","volume":"18","author":"Chae","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib19","series-title":"Advances in bioengineering","first-page":"139","article-title":"Protein misfolding and aggregation of tau protein in Alzheimer\u2019s disease","author":"Chandrashekar","year":"2020"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib20","article-title":"Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity","volume":"10","author":"Chen","year":"2015","journal-title":"PloS ONE"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0021-9258(17)36041-6","article-title":"A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase","volume":"261","author":"Cheng","year":"1986","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.009_bib22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jcb.22864","article-title":"Identification of p10 as a neurotoxic product generated from the proteolytic cleavage of the neuronal Cdk5 activator","volume":"111","author":"Chew","year":"2010","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroscience.2020.04.019","article-title":"G-Protein coupled receptors and tau-different roles in Alzheimer\u2019s disease","volume":"438","author":"Chidambaram","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13578-020-00474-4","article-title":"Interaction of tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation","volume":"10","author":"Chidambaram","year":"2020","journal-title":"Cell & Bioscience"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151201","article-title":"G-protein coupled purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin cytoskeleton remodeling in microglia","volume":"101","author":"Chidambaram","year":"2022","journal-title":"European Journal of Cell Biology"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib26","series-title":"Tau protein: Methods and protocols","first-page":"33","article-title":"Interaction of tau with G-protein-coupled purinergic P2Y12 receptor by molecular docking and molecular dynamic simulation","author":"Chidambaram","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib27","unstructured":"Chinnathambi, S. (2011). Influence of phosphorylation on the pathological conformation of human microtubule associated protein tau Staats-und Universit\u00e4tsbibliothek Hamburg Carl von Ossietzky."},{"key":"10.1016\/bs.apcsb.2025.08.009_bib28","article-title":"Alzheimer\u2019s disease pathology: A tau perspective","volume":"58","author":"Chinnathambi","year":"2022","journal-title":"Alzheimer\u2019s Disease"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib29","series-title":"Advances in protein chemistry and structural biology","article-title":"Histone deacetylase\u2019s regulates tau function in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib30","series-title":"Advances in protein chemistry and structural biology","article-title":"Small molecule-mediated therapeutic approaches to target tau and Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib31","series-title":"Advances in protein chemistry and structural biology","article-title":"Tau proteotasis in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib32","series-title":"Advances in protein chemistry and structural biology","article-title":"Nuclear transport protein suppresses tau neurodegeneration","author":"Chinnathambi","year":"2024"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13578-023-01028-0","article-title":"Microglia degrade tau oligomers deposit via purinergic P2Y12-associated podosome and filopodia formation and induce chemotaxis","volume":"13","author":"Chinnathambi","year":"2023","journal-title":"Cell & Bioscience"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.009_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119477","article-title":"Tau aggregates improve the purinergic receptor P2Y12-associated podosome rearrangements in microglial cells","volume":"1870","author":"Chinnathambi","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/bs.apcsb.2024.04.002","article-title":"The crosstalk between extracellular matrix proteins and tau","volume":"141","author":"Chinnathambi","year":"2024","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.33594\/000000621","article-title":"Photo-excited toluidine blue disaggregates the repeat tau and modulates end-binding protein EB1, cytoskeletal structure in neuronal cells","volume":"57","author":"Chinnathambi","year":"2023","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib37","series-title":"Advances in protein chemistry and structural biology","article-title":"Modifiable chemical risk factors for amyloid-\u03b2 and tau protein in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib38","series-title":"Advances in protein chemistry and structural biology","article-title":"Tau protein structure and dynamics","author":"Chinnathambi","year":"2024"},{"issue":"7305","key":"10.1016\/bs.apcsb.2025.08.009_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR\u03b3 by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.08.009_bib40","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1093\/hmg\/dds161","article-title":"Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer\u2019s diseases","volume":"21","author":"Coppola","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.chembiol.2015.03.009","article-title":"Tamoxifen inhibits CDK5 kinase activity by interacting with p35\/p25 and modulates the pattern of tau phosphorylation","volume":"22","author":"Corbel","year":"2015","journal-title":"Chemistry & Biology"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107625","article-title":"Macrocyclic peptides derived from AcPHF6\u204e and AcPHF6 to selectively modulate the tau aggregation","volume":"151","author":"Dangi","year":"2024","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijbiomac.2020.01.296","article-title":"Effect of melatonin on tau aggregation and tau-mediated cell surface morphology","volume":"152","author":"Das","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420981204","article-title":"Melatonin reduces GSK3\u03b2-mediated tau phosphorylation, enhances Nrf2 nuclear translocation and anti-inflammation","volume":"12","author":"Das","year":"2020","journal-title":"ASN Neuro"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1694-y","article-title":"Phagocytosis of full-length tau oligomers by actin-remodeling of activated microglia","volume":"17","author":"Das","year":"2020","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-019-1694-y","article-title":"Phagocytosis of full-length tau oligomers by actin-remodeling of activated microglia","volume":"17","author":"Das","year":"2020","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib47","first-page":"1","article-title":"Microglial priming of antigen presentation and adaptive stimulation in Alzheimer\u2019s disease","author":"Das","year":"2019","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43556-021-00036-1","article-title":"G-protein coupled receptor, PI3K and rho signaling pathways regulate the cascades of tau and amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"2","author":"Desale","year":"2021","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijbiomac.2020.10.226","article-title":"\u03b1-Linolenic acid inhibits tau aggregation and modulates tau conformation","volume":"166","author":"Desale","year":"2021","journal-title":"International Journal of Biological Macromolecules"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.009_bib50","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/35096019","article-title":"A decade of CDK5","volume":"2","author":"Dhavan","year":"2001","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108153","article-title":"Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer\u2019s disease","author":"Dubey","year":"2019","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib52","article-title":"Heat stress modulates the GSK-3\u03b2 levels and tau phosphorylation","author":"Dubey","year":"2020","journal-title":"Preprints: Preprints"},{"issue":"20","key":"10.1016\/bs.apcsb.2025.08.009_bib53","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.1021\/acsomega.9b02792","article-title":"Photoexcited toluidine blue inhibits tau aggregation in Alzheimer\u2019s disease","volume":"4","author":"Dubey","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123171","article-title":"Bacopa monnieri reduces tau aggregation and tau-mediated toxicity in cells","volume":"234","author":"Dubey","year":"2023","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112970","article-title":"The inhibitory effect of curcumin-artemisinin co-amorphous on tau aggregation and tau phosphorylation","volume":"221","author":"Dubey","year":"2023","journal-title":"Colloids and surfaces. B, Biointerfaces"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/proteomes12010003","article-title":"The mechanisms of regulated cell death: Structural and functional proteomic pathways induced or inhibited by a specific Protein\u2014A narrative review","volume":"12","author":"Fern\u00e1ndez-L\u00e1zaro","year":"2024","journal-title":"Proteomes"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1568026024607508","article-title":"Peptide inhibitors of beta amyloid aggregation","volume":"2","author":"Findeis","year":"2002","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"21","key":"10.1016\/bs.apcsb.2025.08.009_bib58","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1021\/bi982824n","article-title":"Modified-peptide inhibitors of amyloid \u03b2-peptide polymerization","volume":"38","author":"Findeis","year":"1999","journal-title":"Biochemistry"},{"issue":"S1","key":"10.1016\/bs.apcsb.2025.08.009_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S0007114500002221","article-title":"Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme","volume":"84","author":"FitzGerald","year":"2000","journal-title":"British Journal of Nutrition"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.009_bib60","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.009_bib61","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/156720507783018181","article-title":"New approaches to the discovery of cdk5 inhibitors","volume":"4","author":"Glicksman","year":"2007","journal-title":"Current Alzheimer Research"},{"issue":"14","key":"10.1016\/bs.apcsb.2025.08.009_bib62","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1074\/jbc.M413690200","article-title":"Design of a novel class of peptide inhibitors of cyclin-dependent kinase\/cyclin activation","volume":"280","author":"Gondeau","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.009_bib63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","article-title":"Post-translational modifications of tau protein in Alzheimer\u2019s disease","volume":"112","author":"Gong","year":"2005","journal-title":"Journal of Neural Transmission"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yexmp.2006.09.002","article-title":"Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5","volume":"82","author":"Goodyear","year":"2007","journal-title":"Experimental and Molecular Pathology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12031-018-1174-3","article-title":"Tau protein squired by molecular chaperones during Alzheimer\u2019s disease","volume":"66","author":"Gorantla","year":"2018","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib66","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ijbiomac.2019.11.176","article-title":"Transition metal nickel prevents tau aggregation in Alzheimer\u2019s disease","volume":"156","author":"Gorantla","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/ADR-190118","article-title":"Neem derivatives inhibits tau aggregation","volume":"3","author":"Gorantla","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"issue":"16","key":"10.1016\/bs.apcsb.2025.08.009_bib68","doi-asserted-by":"crossref","first-page":"16702","DOI":"10.1021\/acsomega.9b00692","article-title":"Molecular cobalt(II) complexes for tau polymerization in Alzheimer\u2019s disease","volume":"4","author":"Gorantla","year":"2019","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: The therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends in Molecular Medicine"},{"issue":"5054","key":"10.1016\/bs.apcsb.2025.08.009_bib70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.08.009_bib71","doi-asserted-by":"crossref","first-page":"12555","DOI":"10.1074\/jbc.M600014200","article-title":"Novel peptide inhibitors of human kallikrein 2","volume":"281","author":"Hekim","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"4667","key":"10.1016\/bs.apcsb.2025.08.009_bib72","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.6474172","article-title":"Alzheimer\u2019s disease: Cell-specific pathology isolates the hippocampal formation","volume":"225","author":"Hyman","year":"1984","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib73","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0955-0674(98)80143-9","article-title":"Signal transduction by the c-Jun N-terminal kinase (JNK)\u2014from inflammation to development","volume":"10","author":"Ip","year":"1998","journal-title":"Current Opinion in Cell Biology"},{"issue":"1-2","key":"10.1016\/bs.apcsb.2025.08.009_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3940(95)12206-0","article-title":"Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites","volume":"202","author":"Ishiguro","year":"1995","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib75","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-61779-551-0_7","article-title":"Conformations of microtubule-associated protein tau mapped by fluorescence resonance energy transfer","volume":"849","author":"Jeganathan","year":"2012","journal-title":"Methods in Molecular Biology"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.009_bib76","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00432-010-0837-4","article-title":"Circulating cycloxygenase-2 in patients with tobacco-related intraoral squamous cell carcinoma and evaluation of its peptide inhibitors as potential antitumor agent","volume":"136","author":"Kapoor","year":"2010","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.009_bib77","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2008.10.015","article-title":"Deregulation of HDAC1 by p25\/Cdk5 in neurotoxicity","volume":"60","author":"Kim","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"32","key":"10.1016\/bs.apcsb.2025.08.009_bib79","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/bi060837s","article-title":"N-Methylated peptide inhibitors of \u03b2-amyloid aggregation and toxicity. Optimization of the inhibitor structure","volume":"45","author":"Kokkoni","year":"2006","journal-title":"Biochemistry"},{"issue":"16","key":"10.1016\/bs.apcsb.2025.08.009_bib80","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson\u2019s disease","volume":"339","author":"Lang","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib81","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/BJ20070825","article-title":"Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction","volume":"408","author":"Laudet","year":"2007","journal-title":"Biochemical Journal"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase Kinase-3\u03b2 and CDK5\/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer\u2019s disease a PROPERTY COMMON TO MOST CYCLIN-DEPENDENT KINASE INHIBITORS?","volume":"276","author":"Leclerc","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib83","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbrc.2019.04.166","article-title":"Cdk5 regulates N-cadherin-dependent neuronal migration during cortical development","volume":"514","author":"Lee","year":"2019","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"13","key":"10.1016\/bs.apcsb.2025.08.009_bib84","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4161\/cc.25304","article-title":"CDK5: A new lead to survival","volume":"12","author":"Lew","year":"2013","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.009_bib85","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1074\/jbc.M607234200","article-title":"Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells","volume":"282","author":"Lin","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"28","key":"10.1016\/bs.apcsb.2025.08.009_bib86","doi-asserted-by":"crossref","first-page":"29302","DOI":"10.1074\/jbc.M403664200","article-title":"Involvement of Cdk5\/p25 in digoxin-triggered prostate cancer cell apoptosis","volume":"279","author":"Lin","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/psc.366","article-title":"Peptides as drugs: Is there a market?","volume":"8","author":"Loffet","year":"2002","journal-title":"Journal of Peptide Science: an Official Publication of the European Peptide Society"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.009_bib88","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0962-8924(98)01368-3","article-title":"Tau in Alzheimer\u2019s disease","volume":"8","author":"Mandelkow","year":"1998","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib89","first-page":"a006247","article-title":"Biochemistry and cell biology of tau protein in neurofibrillary degeneration","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib90","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/jm049323m","article-title":"Mechanism of CDK5\/p25 binding by CDK inhibitors","volume":"48","author":"Mapelli","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib91","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3\u03b2 and CK1 by hymenialdisine, a marine sponge constituent","volume":"7","author":"Meijer","year":"2000","journal-title":"Chemistry & Biology"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib92","article-title":"Peptide inhibitors of protein kinase c \u03b3 for pain management","author":"Mochly-Rosen","year":"2008","journal-title":"Google Patents"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1567205043480519","article-title":"Recent evidence regarding a role for Cdk5 dysregulation in Alzheimer\u2019s disease","volume":"1","author":"Monaco","year":"2004","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib94","series-title":"Computational modeling of drugs against Alzheimer\u2019s disease","first-page":"305","article-title":"Molecular modeling of tau proline-directed protein kinase (PDPK) inhibitors","author":"Navarro-Retamal","year":"2018"},{"issue":"6698","key":"10.1016\/bs.apcsb.2025.08.009_bib95","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/26034","article-title":"The p35\/Cdk5 kinase is a neuron-specific rac effector that inhibits Pak1 activity","volume":"395","author":"Nikolic","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib96","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","article-title":"Targeting fyn kinase in Alzheimer\u2019s disease","volume":"83","author":"Nygaard","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.009_bib97","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1242\/dev.02854","article-title":"Cdk5 is required for multipolar-to-bipolar transition during radial neuronal migration and proper dendrite development of pyramidal neurons in the cerebral cortex","volume":"134","author":"Ohshima","year":"2007","journal-title":"Development"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.009_bib98","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/psc.849","article-title":"Activity and stability of human kallikrein\u20102\u2010specific linear and cyclic peptide inhibitors","volume":"13","author":"Pakkala","year":"2007","journal-title":"Journal of Peptide Science: an Official Publication of the European Peptide Society"},{"issue":"6762","key":"10.1016\/bs.apcsb.2025.08.009_bib99","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cancers7010179","article-title":"Targeting cyclin-dependent kinases in human cancers: From small molecules to peptide inhibitors","volume":"7","author":"Peyressatre","year":"2015","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib101","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1124\/jpet.102.047381","article-title":"Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3","volume":"305","author":"Plotkin","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib102","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/jm031016d","article-title":"Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases","volume":"47","author":"Polychronopoulos","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib103","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/bs.apcsb.2024.09.009","article-title":"Nuclear podosomes regulates cellular migration in tau and Alzheimer\u2019s disease","volume":"143","author":"Qureshi","year":"2025","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.009_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119275","article-title":"Histone deacetylase-6 modulates tau function in Alzheimer\u2019s disease","volume":"1869","author":"Qureshi","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib105","series-title":"Multi-factorial approach as a therapeutic strategy for the management of Alzheimer\u2019s disease","first-page":"139","article-title":"Diagnosis of Alzheimer\u2019s disease, types of plaques and their detection, imaging techniques, and other tests","author":"Qureshi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib106","series-title":"Multi-factorial approach as a therapeutic strategy for the management of Alzheimer\u2019s disease","first-page":"113","article-title":"Hurdles and strategies in treating Alzheimer\u2019s disease","author":"Qureshi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib107","article-title":"Extracellular HDAC6 ZnF UBP domain enhances podosome-mediated neuronal migration","author":"Qureshi","year":"2024","journal-title":"bioRxiv"},{"issue":"52","key":"10.1016\/bs.apcsb.2025.08.009_bib108","doi-asserted-by":"crossref","first-page":"49043","DOI":"10.1074\/jbc.M105599200","article-title":"Phosphorylation of Pak1 by the p35\/Cdk5 kinase affects neuronal morphology","volume":"276","author":"Rashid","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.009_bib109","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","article-title":"Subcortical ischaemic vascular dementia","volume":"1","author":"Rom\u00e1n","year":"2002","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/77.2.326","article-title":"A fermented milk high in bioactive peptides has a blood pressure\u2013lowering effect in hypertensive subjects","volume":"77","author":"Seppo","year":"2003","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib111","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1007\/s12035-017-0525-3","article-title":"Tale of the good and the bad Cdk5: Remodeling of the actin cytoskeleton in the brain","volume":"55","author":"Shah","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib112","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-160916","article-title":"TFP5, a peptide inhibitor of aberrant and hyperactive Cdk5\/p25, attenuates pathological phenotypes and restores synaptic function in CK-p25Tg mice","volume":"56","author":"Shukla","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.009_bib113","first-page":"277","article-title":"Cdk5 on the brain","volume":"12","author":"Smith","year":"2001","journal-title":"Cell Growth and Differentiation-Publication American Association for Cancer Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.009_bib114","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1192\/bjp.180.2.140","article-title":"Frontotemporal dementia","volume":"180","author":"Snowden","year":"2002","journal-title":"The British Journal of Psychiatry"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.009_bib115","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1021\/acsomega.9b01411","article-title":"Protein-capped metal nanoparticles inhibit tau aggregation in Alzheimer\u2019s disease","volume":"4","author":"Sonawane","year":"2019","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib116","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12031-018-1111-5","article-title":"Prion-Like propagation of post-translationally modified tau in Alzheimer\u2019s disease: A hypothesis","volume":"65","author":"Sonawane","year":"2018","journal-title":"Journal of Molecular Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib117","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-191348","article-title":"P301 L, an FTDP-17 mutant, exhibits enhanced glycation in vitro","volume":"75","author":"Sonawane","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.009_bib118","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.18632\/oncotarget.27963","article-title":"Epigallocatechin-3-gallate modulates tau post-translational modifications and cytoskeletal network","volume":"12","author":"Sonawane","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib119","series-title":"Alzheimer\u2019s disease: Recent findings in pathophysiology, diagnostic and therapeutic modalities (pp. 0)","article-title":"Alzheimer\u2019s disease pathology: A tau perspective","author":"Sonawane","year":"2022"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12964-021-00704-3","article-title":"Baicalein inhibits heparin-induced tau aggregation by initializing non-toxic tau oligomer formation","volume":"19","author":"Sonawane","year":"2021","journal-title":"Cell Communication and Signaling"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib121","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","article-title":"Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration","volume":"32","author":"Sundaram","year":"2012","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.009_bib122","first-page":"32","article-title":"Oxidative stress in Alzheimer\u2019s disease\u2013evaluating the amyloid beta hypothesis","volume":"13","author":"Swetha","year":"2021","journal-title":"International Journal of Current Pharmaceutical Review and Research"},{"issue":"1-3","key":"10.1016\/bs.apcsb.2025.08.009_bib123","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0014-5793(02)02934-4","article-title":"A survey of Cdk5 activator p35 and p25 levels in Alzheimer\u2019s disease brains","volume":"523","author":"Tseng","year":"2002","journal-title":"FEBS Letters"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.009_bib124","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1299","article-title":"Cdk5-dependent regulation of glucose-stimulated insulin secretion","volume":"11","author":"Wei","year":"2005","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.009_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-003-0703-7","article-title":"Cyclin-dependent kinase 5 (CDK5) and neuronal cell death","volume":"312","author":"Weishaupt","year":"2003","journal-title":"Cell and Tissue Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.009_bib126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0092-8674(03)00605-6","article-title":"Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration","volume":"114","author":"Xie","year":"2003","journal-title":"Cell"},{"key":"10.1016\/bs.apcsb.2025.08.009_bib127","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.expneurol.2013.12.017","article-title":"Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice","volume":"253","author":"Yamada","year":"2014","journal-title":"Experimental Neurology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.009_bib128","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1271\/bbb.56.1541","article-title":"Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito","volume":"56","author":"Yokoyama","year":"1992","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.009_bib129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1021\/np034011s","article-title":"Effects of natural flavones and flavonols on the kinase activity of Cdk5","volume":"67","author":"Zapata-Torres","year":"2004","journal-title":"Journal of Natural Products"},{"issue":"49","key":"10.1016\/bs.apcsb.2025.08.009_bib130","doi-asserted-by":"crossref","first-page":"20041","DOI":"10.1073\/pnas.1212914109","article-title":"p10, the N-terminal domain of p35, protects against CDK5\/p25-induced neurotoxicity","volume":"109","author":"Zhang","year":"2012","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.08.009_bib131","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1046\/j.1432-1033.2002.03133.x","article-title":"A peptide derived from cyclin\u2010dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells","volume":"269","author":"Zheng","year":"2002","journal-title":"European Journal of Biochemistry"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.08.009_bib132","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1523\/JNEUROSCI.3673-13.2014","article-title":"Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors","volume":"34","author":"Zhong","year":"2014","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.009_bib133","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1017\/S1461145711000915","article-title":"Increased Cdk5\/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats","volume":"15","author":"Zhu","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Protein Misfolding Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:50:48Z","timestamp":1764093048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162325000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443294143"],"references-count":133,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2025.08.009","relation":{},"ISSN":["1876-1623"],"issn-type":[{"type":"print","value":"1876-1623"}],"subject":[],"published":{"date-parts":[[2025]]}}}